Eckard Hamelmann
Overview
Explore the profile of Eckard Hamelmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
177
Citations
3071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bal C, Stoshikj S, Renner A, Milger K, Skowasch D, Schulz C, et al.
Pulmonology
. 2025 Feb;
31(1):2460868.
PMID: 39945136
Introduction: Previous studies of anti-IL-5/IL-5(R) therapies in severe asthma found that response was mainly predicted by indicators of good baseline disease control. However, long-term response predictors remain unclear. Methods: Responders...
2.
Biener L, Stoshikj S, Brugger J, Krall C, Buhl R, Hamelmann E, et al.
J Allergy Clin Immunol Pract
. 2025 Feb;
PMID: 39900240
Background: Patients with asthma with >10 pack-years are frequently excluded from asthma trials. Little is known about how smoking affects their characteristics and therefore may impact treatment choices. Objective: To...
3.
Lommatzsch M, Blumchen K, Beck L, Bousquet J, Brusselle G, Fokkens W, et al.
EClinicalMedicine
. 2025 Jan;
80:103050.
PMID: 39867971
Funding: None.
4.
Soler Wenglein J, Simon A, Berner R, Brockmeyer H, Forster J, Hamelmann E, et al.
Eur J Pediatr
. 2025 Jan;
184(2):149.
PMID: 39843792
Conclusions: ABSaP's guidelines may provide a model for others, as well as offer a basis for discussing practical, effective antibiotic stewardship (ABS) measures in pediatric primary care. An international, expert...
5.
Stoshikj S, Biener L, Renner A, Bal C, Brugger J, Krall C, et al.
J Allergy Clin Immunol Pract
. 2025 Jan;
PMID: 39800060
Background: Clinical studies of biologics in severe asthma exclude smokers or ex-smokers (ExS) with over 10 pack-years (py). Thus, the effectiveness of this therapy in ExS with severe asthma is...
6.
Jackson D, Hamelmann E, Roberts G, Bacharier L, Xia C, Gall R, et al.
J Allergy Clin Immunol Pract
. 2024 Nov;
13(3):568-575.
PMID: 39613097
Background: Elevated blood or tissue eosinophils are considered to characterize type 2 inflammation in children with asthma and are associated with increased exacerbation rates and worse asthma control. Dupilumab, a...
7.
Hamelmann E, Csonka P, Roberts G, Vogelberg C, Cichocka-Jarosz E, Just J, et al.
Respir Med
. 2024 Sep;
234:107812.
PMID: 39326679
Respiratory allergy often begins in childhood and most commonly manifests as allergic rhinitis (upper airways) and/or asthma (lower airways). Children with upper respiratory allergy often suffer from coexisting asthma, and...
8.
Winterland S, Schmidt J, Nordhoff D, Barthlen W, Hamelmann E, Gaus S
Clin Case Rep
. 2024 Aug;
12(8):e9324.
PMID: 39156203
After ingestion rubber gloves harden and can produce dangerous complications. Therefore the choice of treatment is of utmost importance. Aside from a surgical approach, endoscopy should also be considered as...
9.
Bal C, Stoshikj S, Milger K, Skowasch D, Gappa M, Koerner-Rettberg C, et al.
Allergy
. 2024 Jun;
79(11):3133-3138.
PMID: 38864229
No abstract available.
10.
Papadopoulos N, Custovic A, Deschildre A, Gern J, Nieto Garcia A, Miligkos M, et al.
Pediatr Allergy Immunol
. 2024 Apr;
35(4):e14129.
PMID: 38664926
Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and...